Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

June 15, 2025

Study Completion Date

June 15, 2026

Conditions
NSCLC
Interventions
DIAGNOSTIC_TEST

ctDNA, tumor NGS

Testing for actionable oncogenic drivers

Trial Locations (21)

10016

RECRUITING

NYU, New York

10032

RECRUITING

Columbia University, New York

22031

RECRUITING

Virginia Cancer Specialists, PC, Fairfax

29425

RECRUITING

Medical University of South Carolina, Charleston

33612

RECRUITING

Moffitt Cancer Center, Tampa

43210

RECRUITING

Ohio State University, Columbus

48109

RECRUITING

University of Michigan, Ann Arbor

60611

RECRUITING

Northwestern University, Chicago

63110

RECRUITING

Washington University, St Louis

65212

RECRUITING

University of Missouri, Columbia

77030

RECRUITING

Baylor College of Medicine, Houston

90033

RECRUITING

USC Norris Comprehensive Cancer Center, Los Angeles

90095

RECRUITING

UCLA, Los Angeles

92868

RECRUITING

St. Joseph's Hospital Orange, Orange

95616

RECRUITING

University of California, Davis, Davis

98019

RECRUITING

University of Washington, Seattle

02114

RECRUITING

Massachusetts General Hospital, Boston

02115

RECRUITING

Brigham and Women's Hospital, Boston

02118

RECRUITING

Boston Medical Center, Boston

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

03756

RECRUITING

Dartmouth-Hitchcock, Lebanon

Sponsors
All Listed Sponsors
collaborator

Lung Cancer Research Foundation

OTHER

lead

Lung Cancer Mutation Consortium

NETWORK